source
- FDA issues warning letters to Bausch & Lomb and Indian API maker over GMP lapsesThe U.S. Food and Drug Administration sent warning letters to two companies after finding violations of good manufacturing practice. Bausch & Lomb, which produces ophthalmic products, was cited f…
- Sionna Therapeutics to lay off 46% of staff after cystic fibrosis trial setbackSionna Therapeutics announced it will cut 46% of its workforce following an unexpected failure in its cystic fibrosis trial. The company, which employed about 59 people, said roughly 27 employees…